DE69133242D1 - Peptide zur verwendung in impfung und anregung von antikörperbildung gegen menschliches immunschwäche virus - Google Patents

Peptide zur verwendung in impfung und anregung von antikörperbildung gegen menschliches immunschwäche virus

Info

Publication number
DE69133242D1
DE69133242D1 DE69133242T DE69133242T DE69133242D1 DE 69133242 D1 DE69133242 D1 DE 69133242D1 DE 69133242 T DE69133242 T DE 69133242T DE 69133242 T DE69133242 T DE 69133242T DE 69133242 D1 DE69133242 D1 DE 69133242D1
Authority
DE
Germany
Prior art keywords
peptides
immunodeficiency virus
human immunodeficiency
against human
vaccination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69133242T
Other languages
English (en)
Other versions
DE69133242T2 (de
Inventor
Anders Vahlne
Bo Svennerholm
Lars Rymo
Stig Jeansson
Peter Horal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tripep AB
Original Assignee
Tripep AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tripep AB filed Critical Tripep AB
Publication of DE69133242D1 publication Critical patent/DE69133242D1/de
Application granted granted Critical
Publication of DE69133242T2 publication Critical patent/DE69133242T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69133242T 1990-09-27 1991-09-25 Peptide zur verwendung in impfung und anregung von antikörperbildung gegen menschliches immunschwäche virus Expired - Fee Related DE69133242T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US58942290A 1990-09-27 1990-09-27
US589422 1990-09-27
PCT/SE1991/000641 WO1992005800A1 (en) 1990-09-27 1991-09-25 Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus

Publications (2)

Publication Number Publication Date
DE69133242D1 true DE69133242D1 (de) 2003-05-28
DE69133242T2 DE69133242T2 (de) 2004-02-19

Family

ID=24357953

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69133242T Expired - Fee Related DE69133242T2 (de) 1990-09-27 1991-09-25 Peptide zur verwendung in impfung und anregung von antikörperbildung gegen menschliches immunschwäche virus

Country Status (13)

Country Link
US (1) US5589175A (de)
EP (1) EP0550599B1 (de)
JP (1) JPH06501260A (de)
AT (1) ATE238065T1 (de)
AU (1) AU650911B2 (de)
CA (1) CA2091263C (de)
DE (1) DE69133242T2 (de)
ES (1) ES2194836T3 (de)
FI (1) FI931393A0 (de)
HU (1) HU9300877D0 (de)
MC (1) MC2308A1 (de)
OA (1) OA09802A (de)
WO (1) WO1992005800A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5939074A (en) * 1986-12-30 1999-08-17 The United States Of America As Represented By The Department Of Health And Human Services Multideterminant peptide antigens
US5346989A (en) * 1990-08-22 1994-09-13 Syntello Vaccine Development Kb Peptides for use in induction of T cell activation against HIV-1
WO1992021377A1 (en) * 1991-06-03 1992-12-10 Syntello Inc. Peptides for use in induction of t cell activation against hiv-1
ES2257733T3 (es) * 1991-08-29 2006-08-01 The Government Of The Usa, As Represented By The Secretary, Department Of Health And Human Services Antigenos peptidicos multideterminantes que estimulan la respuesta de los linfocitos auxiliares al hiv en una amplia gama de humanos.
IT1254360B (it) * 1992-05-11 1995-09-14 San Romanello Centro Fond Epitopi immunologicamente omologhi di hla e proteine del virus hiv.
DE4228787A1 (de) * 1992-08-29 1994-03-03 Chemotherapeutisches Forschungsinstitut Georg Speyer Haus Neue HIV-1-Virusisolate eines Subtyps, Vakzine gegen HIV-1-Virusinfektionen dieses Subtyps und Verfahren zu ihrer Herstellung, Verwendung der HIV-1-Virusisolate
WO1994023746A1 (en) * 1993-04-16 1994-10-27 Syntello Vaccine Development Ab Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus
FR2707170A1 (fr) * 1993-06-04 1995-01-13 Pasteur Institut Expression des récepteurs CD4 et CD26 dans des cellules recombinantes, inhibiteurs du récepteur CD26.
FR2707169B1 (fr) * 1993-06-04 1995-09-01 Pasteur Institut Antigène cellulaire CD26 impliqué dans l'infection par un rétrovirus hiv. nouveaux inhibiteurs de l'infection par HIV. * (Dipeptidyl-peptidase IV).
DE4405810A1 (de) 1994-02-23 1995-08-24 Behringwerke Ag Von einem Retrovirus aus der HIV-Gruppe abgeleitete Peptide und deren Verwendung
AU2991197A (en) * 1996-04-15 1997-11-07 University Of North Carolina At Chapel Hill, The Antigenic sequences of a sperm protein and immunocontraceptive methods
US7048929B1 (en) * 1997-11-10 2006-05-23 Dana-Farber Cancer Institute, Inc. Stabilized primate lentivirus envelope glycoproteins
ES2657480T3 (es) 2006-08-11 2018-03-05 Life Sciences Research Partners Vzw Péptidos inmunogénicos y su uso en trastornos inmunitarios
CA2715611C (en) 2008-02-14 2018-03-13 Life Sciences Research Partners Vzw Immunotherapy targeting intracellular pathogens
EP2623115A1 (de) 2008-02-14 2013-08-07 Life Sciences Research Partners VZW Immunogene Beeinflussung von Tumoren und Tumorzellen
HUE055070T2 (hu) * 2010-11-25 2021-10-28 Imnate Sarl Immunogén peptidek fertõzõ betegségek, autoimmun betegségek, allofaktorokra adott immunválaszok, allergiás betegségek, tumorok, graftkilökõdés, és génterápiához vagy génvakcinációhoz alkalmazott vírusvektorokkal szembeni immunválaszok megelõzésében és/vagy kezelésében történõ alkalmazásra
GB201201511D0 (en) 2012-01-30 2012-03-14 Univ Leuven Kath Modified epitopes for boosting CD4+ T-cell responses
GB201309469D0 (en) 2013-05-28 2013-07-10 Imcyse Sa Detection of CD4+ T lymphocytes
US10729791B2 (en) 2015-05-18 2020-08-04 Imcyse Sa Animal models for evaluating pharmaceutical compounds
ES2874077T3 (es) 2015-09-25 2021-11-04 Imcyse Sa Métodos y compuestos mejorados para eliminar respuestas inmunitarias a agentes terapéuticos
KR20240015731A (ko) 2016-04-19 2024-02-05 임시스 에스에이 신규 면역원성 CD1d 결합 펩티드

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3588248T2 (de) * 1984-10-18 2004-07-01 Institut Pasteur LAV-Antigene und -Peptide
AU617088B2 (en) * 1986-06-12 1991-11-21 Biogen, Inc. Peptides involved in the pathogenesis of hiv infection
US5128319A (en) * 1987-08-28 1992-07-07 Board Of Regents, The University Of Texas System Prophylaxis and therapy of acquired immunodeficiency syndrome
US5019387A (en) * 1987-09-08 1991-05-28 Duke University Production of antibodies to HIV
WO1989005820A1 (en) * 1987-12-21 1989-06-29 Arch Development Corporation Hiv-related antigens and antibodies
EP0330359A3 (de) * 1988-02-25 1991-06-05 Bio-Rad Laboratories, Inc. Zusammensetzung, verwendbar zur Diagnose und Behandlung von HIV-I-Infektion
AU3557889A (en) * 1988-04-20 1989-11-24 Trustees Of The University Of Pennsylvania, The Protective peptides derived from human immunodeficiency virus-1 gp160
US4943628A (en) * 1988-06-13 1990-07-24 Ortho Pharmaceutical Corporation HIV peptide-inducted T cell stimulation
WO1991015512A2 (en) * 1990-04-03 1991-10-17 Genentech, Inc. Hiv envelope polypeptides
AP237A (en) * 1990-05-29 1993-04-29 Cedars Sinai Medical Center Immunoreagents reactive with a conserved epitope of human immunodeficiency virus type 1 (HIV-1) gp120 and methods of use.
WO1992021377A1 (en) * 1991-06-03 1992-12-10 Syntello Inc. Peptides for use in induction of t cell activation against hiv-1

Also Published As

Publication number Publication date
US5589175A (en) 1996-12-31
OA09802A (en) 1994-04-15
CA2091263C (en) 2003-05-06
FI931393A (fi) 1993-03-26
WO1992005800A1 (en) 1992-04-16
ATE238065T1 (de) 2003-05-15
AU650911B2 (en) 1994-07-07
ES2194836T3 (es) 2003-12-01
JPH06501260A (ja) 1994-02-10
EP0550599A1 (de) 1993-07-14
DE69133242T2 (de) 2004-02-19
CA2091263A1 (en) 1992-03-28
EP0550599B1 (de) 2003-04-23
AU8643591A (en) 1992-04-28
MC2308A1 (fr) 1993-09-27
FI931393A0 (fi) 1993-03-26
HU9300877D0 (en) 1993-06-28

Similar Documents

Publication Publication Date Title
DE69133242D1 (de) Peptide zur verwendung in impfung und anregung von antikörperbildung gegen menschliches immunschwäche virus
CU22615A1 (es) Procedimiento de obtención de anticuerpos monoclonales murinos menos inmunogénicos. anticuerpos monoclonales obtenidos
DE69733960D1 (de) Verwendung von antikörpen gegen cd45ro leukozytenantigen zur immunmodulation
DE68918867T2 (de) Mutanten des hiv-1 Hüllproteins mit fehlenden hypervariabelen domänen.
TR199801722T2 (xx) Peptit imm�nojenler.
ES2013328A6 (es) Un metodo para detectar anticuerpos contra antigenos hiv-1.
ES2129487T3 (es) Peptidos sinteticos, anticuerpos dirigidos contra ellos y su utilizacion.
HUP0103650A2 (hu) Vírusburok-proteinek epitópjai és az ellenük termelt ellenanyagok alkalmazása HCV-vírusantigén gazdaszövetből történő kimutatására
ATE135743T1 (de) Monoklonale menschliche antikörper gegen hiv-i
EP0492560A3 (en) Human monoclonal antibodies directed against the transmembrane glycoprotein (gp41) of hiv-1, and related peptides
ATE285418T1 (de) Humanisierter antikörper spezifisch für das oberflächenantigen pre-s1 von hbv und dessen präparation
ATE119203T1 (de) Monoklonale antikörper von mäusen gegen das gp41 protein von menschlichem immunmangelsyndrom- virus.
FI925321A0 (fi) Immunodiagnostiskt ledinflammationstest
BR9105717A (pt) Receptor poli-ig sintetico,complexos de receptor-anticorpo,sua producao e uso
ATE230418T1 (de) Monoklonaler antikörper gegen das humane mx- protein mxa
ATE343592T1 (de) Gegen ein peptid, das ein kryptisches epitop von gp41 aus hiv-1 nachahmt gerichteter antikörper
EP1104310A4 (de) Expression und charakterisierung eines hiv-1 hüllproteins, das mit einer breitreaktiven neutralisierenden antikörperantwort assoziiert ist.
DE69840628D1 (de) Nicht-anaphylaktische allergenarten und ihre verwendung
DE69433057D1 (de) Peptide zur verwendung bei der impfung und induktion neutralisierender antikörper gegen das menschliche immunschwäche-virus
HUP0003511A2 (hu) Hepatitisz-B-vírus polipeptidek
ATE134649T1 (de) Arzneimittel und verfahren zur behandlung von erworbenem immundefizienzsyndrom (aids) und aids- verwandtem komplex unter verwendung von karbohydratspezifischen antikörpern
RU93004854A (ru) Пептиды для вакцинации и индукции нейтрализующих антител против вируса иммунодефицита человека
DE69010897D1 (de) Verwendung von monoklonalen Antikörpern gegen B2-Mikroglobulin.
HUP0301085A2 (hu) Új peptid és alkalmazása szelektálási eljárásra
ATE126238T1 (de) Monoklonale antikörper gegen gag-protein- vorläufer-p55 von hiv-virus.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee